Insider Buying: HCA Healthcare, Inc. (NYSE:HCA) Major Shareholder Acquires 89,100 Shares of Stock

HCA Healthcare, Inc. (NYSE:HCAGet Rating) major shareholder Thomas F. Frist, Jr. bought 89,100 shares of the firm’s stock in a transaction that occurred on Monday, May 2nd. The stock was acquired at an average cost of $211.93 per share, with a total value of $18,882,963.00. Following the transaction, the insider now owns 478,955 shares of the company’s stock, valued at approximately $101,504,933.15. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

HCA stock opened at $224.80 on Thursday. The company has a 50 day simple moving average of $251.73 and a 200 day simple moving average of $247.40. The stock has a market cap of $67.89 billion, a price-to-earnings ratio of 10.58, a P/E/G ratio of 1.26 and a beta of 1.61. HCA Healthcare, Inc. has a 1 year low of $199.76 and a 1 year high of $279.02. The company has a debt-to-equity ratio of 87.46, a current ratio of 1.43 and a quick ratio of 1.24.

HCA Healthcare (NYSE:HCAGet Rating) last posted its earnings results on Friday, April 22nd. The company reported $4.12 earnings per share for the quarter, missing the Zacks’ consensus estimate of $4.25 by ($0.13). HCA Healthcare had a return on equity of 405.72% and a net margin of 11.40%. The business had revenue of $14.95 billion for the quarter, compared to the consensus estimate of $14.72 billion. During the same period in the previous year, the firm earned $4.14 earnings per share. The company’s revenue was up 6.9% compared to the same quarter last year. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 17.15 EPS for the current fiscal year.

HCA Healthcare announced that its board has approved a share buyback plan on Thursday, January 27th that permits the company to repurchase $8.00 billion in outstanding shares. This repurchase authorization permits the company to repurchase up to 10.9% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s board believes its stock is undervalued.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 30th. Shareholders of record on Thursday, June 16th will be issued a dividend of $0.56 per share. This represents a $2.24 dividend on an annualized basis and a yield of 1.00%. The ex-dividend date is Wednesday, June 15th. HCA Healthcare’s payout ratio is 10.54%.

A number of brokerages have recently commented on HCA. BMO Capital Markets decreased their price objective on shares of HCA Healthcare from $275.00 to $240.00 in a research report on Tuesday, April 26th. Citigroup reduced their target price on shares of HCA Healthcare from $277.00 to $254.00 and set a “buy” rating for the company in a report on Monday, April 25th. UBS Group cut their price objective on shares of HCA Healthcare from $289.00 to $241.00 and set a “buy” rating for the company in a report on Tuesday, April 26th. Wells Fargo & Company cut their price objective on shares of HCA Healthcare from $267.00 to $227.00 and set an “equal weight” rating for the company in a report on Monday, April 25th. Finally, TheStreet raised shares of HCA Healthcare from a “c+” rating to a “b-” rating in a report on Monday, March 21st. Seven equities research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $259.27.

Large investors have recently bought and sold shares of the company. KBC Group NV boosted its stake in shares of HCA Healthcare by 36.4% in the 3rd quarter. KBC Group NV now owns 408,751 shares of the company’s stock valued at $99,212,000 after purchasing an additional 109,068 shares during the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its stake in shares of HCA Healthcare by 10.8% in the 4th quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 117,836 shares of the company’s stock valued at $29,940,000 after purchasing an additional 11,453 shares during the last quarter. Wolf Group Capital Advisors boosted its stake in shares of HCA Healthcare by 205.4% in the 4th quarter. Wolf Group Capital Advisors now owns 34,990 shares of the company’s stock valued at $8,990,000 after purchasing an additional 23,533 shares during the last quarter. Kings Point Capital Management boosted its stake in HCA Healthcare by 1.6% during the third quarter. Kings Point Capital Management now owns 75,300 shares of the company’s stock worth $18,277,000 after acquiring an additional 1,201 shares in the last quarter. Finally, Cim Investment Management Inc. bought a new position in HCA Healthcare during the third quarter worth $638,000. 67.87% of the stock is currently owned by institutional investors.

HCA Healthcare Company Profile (Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Further Reading

Insider Buying and Selling by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.